Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...

Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of circular RNA medicines and unprecedented lipid nanoparticle (LNP) delivery solutions for oncology and ...

Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.

Vertex Pharmaceuticals Inc. will work with a Watertown biotech on new gene-editing therapies for people with sickle cell ...

Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...

“I’ve become something,” she said. “I don’t know what to call it, but people write to me a lot, from all over the world.” (JTA) — Since the Showtime docuseries “Couples Therapy ...

Vertex partners with Orna Therapeutics to develop in vivo gene editing treatments for sickle cell disease and beta ...

just as our beloved Omer showed until the very end,” Omer’s parents Ronen and Orna and brother Daniel say in a joint statement, expressing their gratitude for the support they have received ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Ronen and Orna Neutra are gathering this Thanksgiving with friends in Long Island, New York, for a moment of quiet reflection as their son Omer, an Israeli-American citizen, continues to be held ...